clinical trial · NCT06487585
ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)
University of Maryland St. Joseph Medical Center·phase4·recruiting·n = 100
Vasodilatory Hypotension During or After Cardiac SurgeryAngiotensin II
brief summary
The purpose of this research is to evaluate the use of Angiotensin II in patients with low blood pressure post-surgery. Your information will be collected for 28 days post the procedure and initiation of the study drug to assess for safety events and complications.
started
May 6, 2025
primary completion
Jan 1, 2026
completion
Feb 1, 2026
last updated
Dec 22, 2025
official title
Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery (ANG-First Trial)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol